As of early November 2026, global surveillance by the WHO and CDC shows no novel pathogen meeting pandemic criteria, with routine respiratory virus activity remaining within seasonal baselines and no sustained community transmission of high-consequence strains. Official case reporting and genomic sequencing data indicate typical circulation of known influenza and SARS-CoV-2 variants rather than a new outbreak capable of rapid global spread. This absence of qualifying events through the first ten months underpins the 97.2% market-implied probability of no pandemic. Late-year zoonotic spillovers or undetected variants could still emerge before year-end, though historical patterns and current monitoring thresholds make such shifts unlikely within the remaining timeframe.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedView resolved

Beware of external links.
Beware of external links.
Frequently Asked Questions